HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Constance H Keyserling Selected Research

CER-001

5/2017Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings.
5/2015The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.
3/2015Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Constance H Keyserling Research Topics

Disease

2Rare Diseases (Rare Disease)
05/2015 - 03/2015
1Atherosclerotic Plaque (Atheroma)
05/2017
1Homozygous Familial Hypercholesterolemia
05/2015
1Cardiovascular Diseases (Cardiovascular Disease)
05/2015
1Inflammation (Inflammations)
03/2015
1Hypoalphalipoproteinemias (Hypoalphalipoproteinemia)
03/2015

Drug/Important Bio-Agent (IBA)

3CER-001IBA
05/2017 - 03/2015
2CholesterolIBA
05/2017 - 03/2015
1LipidsIBA
05/2017
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2015
1HDL LipoproteinsIBA
05/2015
1LDL Lipoproteins (beta Lipoproteins)IBA
05/2015
1LDL CholesterolIBA
05/2015
1oxidized low density lipoproteinIBA
05/2015
1Apolipoprotein A-I (Apolipoprotein A1)IBA
05/2015
1SterolsIBA
03/2015
1Lipoproteins (Lipoprotein)IBA
03/2015

Therapy/Procedure

1Therapeutics
05/2015